| Dr Jolene Nichols, LCAC | |
|
11511 W 83rd Ter, Lenexa, KS 66214-1532 | |
| (844) 202-8160 | |
| Not Available |
| Full Name | Dr Jolene Nichols |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 11511 W 83rd Ter, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588227284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 162 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jolene Nichols, LCAC 17182 S Killcreek Rd, Gardner, KS 66030-7848 Ph: (785) 202-0140 | Dr Jolene Nichols, LCAC 11511 W 83rd Ter, Lenexa, KS 66214-1532 Ph: (844) 202-8160 |
News Archive
Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).
TRIUMF, Canada's particle accelerator center, and Canadian Nuclear Laboratories, Canada's premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the commercial production of Actinium-225, a rare medical isotope that has the potential to serve as the basis of new ground-breaking cancer treatments.
Population-wide use of facemasks keeps the coronavirus 'reproduction number' under 1.0, and prevents further waves of the virus when combined with lockdowns, a modelling study from the universities of Cambridge and Greenwich suggests.
A research team at the Helen F. Graham Cancer Center at Christiana Care Health System and the Center for Translational Cancer Research performs a key role in a prestigious National Institutes of Health research project grant of $2.5 million to continue groundbreaking work into the creation of artificial salivary glands.
Carnegie Mellon University researchers have identified a new anticonvulsant compound that has the potential to stop the development of epilepsy. The findings are published in the March issue of the journal Epilepsia.
› Verified 5 days ago
Misha Khan, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Lenexa, KS 66214 Phone: 913-677-3553 | |
Rebecca Lynn Johnston, LMLP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Laura Mae Knight, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12351 W 96th Ter Ste 108, Lenexa, KS 66215 Phone: 913-298-1907 | |
Christine Lopez, LMLP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Lenexa, KS 66214 Phone: 913-677-3553 | |
Jessica M Rawlings, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 15717 College Blvd, Lenexa, KS 66219 Phone: 913-621-2016 Fax: 913-371-0509 | |
Joshua Tanguay, LMLP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Suite 100, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Brittany Noel Loucks, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12351 W 96th Ter Ste 108, Lenexa, KS 66215 Phone: 913-491-6876 |